Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vsee Health (VSEE) Receivables (2023 - 2025)

Vsee Health (VSEE) has disclosed Receivables for 3 consecutive years, with $2.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Receivables rose 80.85% year-over-year to $2.9 million, compared with a TTM value of $2.9 million through Sep 2025, up 80.85%, and an annual FY2024 reading of $2.2 million, up 272.51% over the prior year.
  • Receivables was $2.9 million for Q3 2025 at Vsee Health, up from $1.9 million in the prior quarter.
  • Across five years, Receivables topped out at $2.9 million in Q3 2025 and bottomed at $603480.0 in Q4 2023.
  • Average Receivables over 3 years is $1.9 million, with a median of $1.9 million recorded in 2025.
  • The sharpest move saw Receivables surged 272.51% in 2024, then grew 8.7% in 2025.
  • Year by year, Receivables stood at $603480.0 in 2023, then soared by 272.51% to $2.2 million in 2024, then rose by 27.36% to $2.9 million in 2025.
  • Business Quant data shows Receivables for VSEE at $2.9 million in Q3 2025, $1.9 million in Q2 2025, and $2.1 million in Q1 2025.